From the Journals

DOACs’ safety affirmed in real-world setting


 

FROM THE BMJ

The study was supported by a grant from the National Institute for Health Research. The investigators had no relevant disclosures.

SOURCE: Vinogradova Y et al. BMJ 2018; 362:K2505.

Pages

Recommended Reading

Design limitations may have compromised DVT intervention trial
MDedge Cardiology
DOAC’s edge over warfarin fades with low adherence
MDedge Cardiology
RBC transfusions with surgery may increase VTE risk
MDedge Cardiology
Low vitamin D linked with DVT in lupus patients
MDedge Cardiology
Midlife retinopathy predicts ischemic stroke
MDedge Cardiology
Canakinumab cut gout attacks in CANTOS
MDedge Cardiology
Amplatzer Amulet slashes stroke risk in A-fib
MDedge Cardiology
New look at ATLAS suggests rivaroxaban may still have role in ACS
MDedge Cardiology
TAVR-related stroke risk unrelated to anatomy
MDedge Cardiology
DOJ lawsuit reins in inappropriate ICD use
MDedge Cardiology